| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/26/2006 | CN1809380A Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 07/26/2006 | CN1809348A Pharmaceutical formulations comprising amoxicillin and clavulanante |
| 07/26/2006 | CN1807621A Exterior guiding gene T7 concurrently used with RnaseP ribozyme and its uses |
| 07/26/2006 | CN1807620A Exterior guiding gene T6 concurrently used with RnaseP ribozyme and its uses |
| 07/26/2006 | CN1807619A Exterior guiding gene C6 concurrently used with RnaseP ribozyme and its uses |
| 07/26/2006 | CN1807452A Helicobacter Pylori urease B subunit Th epitope peptide, its coding DNA, vaccine and uses |
| 07/26/2006 | CN1807427A Oxazolidinone analog compound containing triazol radical and its preparation method and uses |
| 07/26/2006 | CN1806842A Capsule for treating AIDS and its preparation method |
| 07/26/2006 | CN1806834A Chinese medicine for treating AIDS |
| 07/26/2006 | CN1806829A Medicinal extract for treating hepatitis |
| 07/26/2006 | CN1806825A Ointment for treating beriberi |
| 07/26/2006 | CN1806809A Organic germanium injection and preparation process thereof |
| 07/26/2006 | CN1806802A Pharmaceutical composition with acetaminopher, loratadine and pseudoephedrine sulfate as active ingredients, preparation method and uses thereof |
| 07/26/2006 | CN1806646A Lily tea with health-preserving function |
| 07/26/2006 | CN1266162C Nucleotide specific to shigella bodyii 10 O-antigen |
| 07/26/2006 | CN1266156C Synthesis process for Adefovir ester of anti hepatitis type B virus medicine |
| 07/26/2006 | CN1266140C Process for preparing oxazolines from tetrahydrofurans |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1265841C Swing breeding and respiratory syndrome suicide DNA vaccine and use |
| 07/26/2006 | CN1265832C External used medicines for Hong Kong foot and tinea manum |
| 07/26/2006 | CN1265820C Compound solanum lyratum injection agent for animal |
| 07/26/2006 | CN1265809C Chinese medicine composition and its preparing method |
| 07/26/2006 | CN1265796C SARS preventing medicine |
| 07/26/2006 | CN1265790C Anti-fungal remedy formulation for external application |
| 07/25/2006 | US7081538 Substituted isoxazolines and their use as antibacterial agents |
| 07/25/2006 | US7081525 Crystal forms of azithromycin |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081476 Tocopherol enriched compositions for reducing IL6 levels |
| 07/25/2006 | US7081342 Using attenuated viral sequence to develop vaccines to prevent porcine reproductive and respiratory syndrome in swine; immunotherapy |
| 07/25/2006 | US7081244 Genetic engineering; vaccines; induction immunology response, antibodies |
| 07/25/2006 | US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway |
| 07/25/2006 | CA2186245C Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 07/25/2006 | CA2168921C 1,6-naphthyridonecarboxylic acid derivatives |
| 07/25/2006 | CA2129564C 2-.beta.-alkenyl penam sulfones as .beta.-lactamase inhibitors |
| 07/25/2006 | CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof |
| 07/20/2006 | WO2006076529A1 Indole derivatives for treating viral infections |
| 07/20/2006 | WO2006076014A2 Interferon-alpha constructs for use in the treatment of sars |
| 07/20/2006 | WO2006075668A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES |
| 07/20/2006 | WO2006075580A1 Antibacterial substances injuring bacterial cell membarane and methods of using the same |
| 07/20/2006 | WO2006075395A1 β-LACTAM ANTIBIOTIC ACTIVITY ENHANCER AND PROCESS FOR PRODUCING THE SAME |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006074501A1 Peptidic compounds |
| 07/20/2006 | WO2006056877A3 Diazepine oxazolidinones as antibacterial agents |
| 07/20/2006 | WO2006047756A3 Substituted tetracycline compounds |
| 07/20/2006 | WO2006032472A3 Immunogenic composition for use in vaccination against staphylococcei |
| 07/20/2006 | WO2005102392A3 Combinations for treating hiv infection |
| 07/20/2006 | WO2003084467A3 Epitope constructs comprising antigen presenting cell targeting mechanisms |
| 07/20/2006 | US20060161007 Oxazole and thiazole combinatorial libraries |
| 07/20/2006 | US20060161002 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160802 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160765 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 07/20/2006 | US20060160731 Peptide nucleic acids |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | US20060159703 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 07/20/2006 | US20060159701 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| 07/20/2006 | US20060159700 Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation |
| 07/20/2006 | US20060159699 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/20/2006 | US20060159697 Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof |
| 07/20/2006 | US20060159669 Novel uses of PPAR modulators and professional APCs manipulated by the same |
| 07/20/2006 | US20060159638 O/W emulsions comprising micronized biologically active agents |
| 07/20/2006 | US20060159626 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 07/20/2006 | DE10227938B4 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 07/20/2006 | DE102005000719A1 Pharmazeutische Zusammensetzung zur kontrollierten Freisetzung von ß-Lactam-Antibiotika in Kombination mit ß-Lactamase-Inhibitoren A pharmaceutical composition for controlled release of beta-lactam antibiotics in combination with beta-lactamase inhibitors |
| 07/20/2006 | DE10134445B4 Bis-acylharnstoffe, deren Derivate sowie deren Verwendung Up-acylureas, their derivatives and their use |
| 07/20/2006 | CA2594411A1 Peptidic biaryl antibacterial compounds comprising one or more basic amino acids |
| 07/20/2006 | CA2593450A1 Indole derivatives for treating viral infections |
| 07/20/2006 | CA2592723A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | CA2587321A1 Improved prrs vaccines |
| 07/20/2006 | CA2562224A1 Nucleoside derivatives for treating hepatitis c virus infection |
| 07/19/2006 | EP1681350A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681062A1 Antibacterial drug for propionibacterium acnes |
| 07/19/2006 | EP1681050A1 Dispersible sustained release pharmaceutical compositions |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680449A1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof |
| 07/19/2006 | EP1680138A1 Combination therapy |
| 07/19/2006 | EP1680133A2 High affinity ligands for influenza virus and methods for their production |
| 07/19/2006 | EP1463812A4 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 07/19/2006 | EP1444215B1 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 07/19/2006 | EP1442058B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/19/2006 | EP1395273B1 Targeted delivery of drugs for the treatment of viral infections |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1299361B1 Pyrazole derivatives |
| 07/19/2006 | EP1255815B1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 07/19/2006 | EP1220684B1 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/19/2006 | EP1181298B1 Novel 8a- and 9a-15-membered lactams |
| 07/19/2006 | EP1164991A4 Gels formed by the interaction of poly(aldehyde) with various substances |
| 07/19/2006 | EP1076566B1 Attenuated mutants of salmonella which constitutively express the vi antigen |
| 07/19/2006 | EP0988314B1 Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 07/19/2006 | EP0966481B1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 07/19/2006 | EP0690724B1 Chlamydia vaccine comrising anti-idiotypic antibodies |
| 07/19/2006 | CN1805966A Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs |
| 07/19/2006 | CN1805757A Recombinant antibodies, and compositions and methods for making and using the same |